Revenue
attach_money28,866M CNY
YoY +10.2%
SBHMYSino Biopharmaceutical Limited$ --
Sino Biopharmaceutical Limited
SBHMY
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2024 Full YearUpdated: 12/31/2024
Operating Income
bar_chart6,136M CNY
YoY +6.0%
Net Income
verified3,500M CNY
YoY +50.1%
EPS
pie_chart4CNY
YoY +153.2%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress-No forecast
Revenue Progress17.6B
Revenue Forecast230.7B
Net Income Progress3.4B
Net Income Forecast0
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.